04 March 2023>: Clinical Research
Perfusate Neutrophil Gelatinase-Associated Lipocalin, Kidney Injury Molecular-1, Liver-Type Fatty Acid Binding Protein, and Interleukin-18 as Potential Biomarkers to Predict Delayed Graft Function and Long-Term Prognosis in Kidney Transplant Recipients: A Single-Center Retrospective Study
Zejia Sun AEF* , Zihao Gao ACE* , Xin Li ABC* , Xiang Zheng BD , Wei Wang AEG#* , Peng Qiao AEF#*DOI: 10.12659/MSM.938758
Med Sci Monit 2023; 29:e938758
Table 2 Comparison of perfusate kidney injury biomarker levels between patients diagnosed with DGF and NON-DGF.
Biomarker | DGF (n=14) | NON-DGF (n=88) | P valuea |
---|---|---|---|
NGAL (ng/ml) | 203.67±44.27 | 147.03±40.34 | |
L-FABP (ng/ml) | 2153.33±1467.10 | 1987.84±1387.54 | 0.682 |
KIM-1 (ng/ml) | 190.86±42.94 | 135.27±39.38 | |
IL-18 (pg/ml) | 278.48±153.37 | 241.04±171.47 | 0.444 |
Values are given as mean±SD. a test. NGAL – neutrophil gelatinase-associated lipocalin; L-FABP – liver-type fatty acid binding protein; KIM-1 – kidney injury molecular-1; IL-18 – interleukin-18; DGF – delayed graft function; OR – odds ratio. |